A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin.
Yifeng Xia, Yi-Liang Liu, Yonghua Xie, Wei Zhu, Francisco Guerra, Shen Shen, Narayana Yeddula, Wolfgang Fischer, William Low, Xiaoying Zhou, Yonghui Zhang, Eric Oldfield, Inder M Verma
文献索引:Sci. Transl. Med. 6(263) , 263ra161, (2014)
全文:HTML全文
摘要
Lung cancer is the most common human malignancy and leads to about one-third of all cancer-related deaths. Lung adenocarcinomas harboring KRAS mutations, in contrast to those with EGFR and EML4-ALK mutations, have not been successfully targeted. We describe a combination therapy for treating these malignancies with two agents: a lipophilic bisphosphonate and rapamycin. This drug combination is much more effective than either agent acting alone in the KRAS G12D-induced mouse lung model. Lipophilic bisphosphonates inhibit both farnesyl and geranylgeranyldiphosphate synthases, effectively blocking prenylation of KRAS and other small G proteins (heterotrimeric GTP-binding protein, heterotrimeric guanine nucleotide-binding proteins) critical for tumor growth and cell survival. Bisphosphonate treatment of cells initiated autophagy but was ultimately unsuccessful and led to p62 accumulation and concomitant nuclear factor κB (NF-κB) activation, resulting in dampened efficacy in vivo. However, we found that rapamycin, in addition to inhibiting the mammalian target of rapamycin (mTOR) pathway, facilitated autophagy and prevented p62 accumulation-induced NF-κB activation and tumor cell proliferation. Overall, these results suggest that using lipophilic bisphosphonates in combination with rapamycin may provide an effective strategy for targeting lung adenocarcinomas harboring KRAS mutations. Copyright © 2014, American Association for the Advancement of Science.
相关化合物
相关文献:
2015-10-30
[J. Chromatogr. A. 1418 , 140-9, (2015)]
2014-11-01
[Gynecol. Oncol. 135(2) , 333-41, (2014)]
2014-12-01
[Br. J. Pharmacol. 171(24) , 5708-27, (2014)]
2015-07-01
[Biochim. Biophys. Acta 1850 , 1415-25, (2015)]
2014-01-01
[Mol. Brain 7 , 85, (2015)]